Rebecca Larson

10PUBLICATIONS
78CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 24, 2026
Genomic correlates of clinical CAR T cell activity.

|Dec 30, 2025
Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignancies.

Adila Izgutdina, Tasfia Rashid, William C Temple

|Jun 05, 2024
Comparative analysis of Bcl-2 family protein overexpression in CAR T cells alone and in combination with BH3 mimetics.

Felix Korell, Michael L Olson, Diego Salas-Benito

|May 09, 2024
Stealth transgenes enable CAR-T cells to evade host immune responses.

Korneel Grauwet, Trisha Berger, Michael C Kann

|Feb 23, 2024
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma.

Marc Wehrli, Samantha Guinn, Filippo Birocchi

|Dec 20, 2023
Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7.

Michael C Kann, Emily M Schneider, Antonio J Almazan

Pageof 2

Frequent Collaborators

10 joint publications

Marcela V Maus

5 joint publications

Mark B Leick

4 joint publications

Michael C Kann

3 joint publications

Andrea Schmidts